21 May 2018
News and Views
Links and Services
A study in the latest issue of the Alimentary Pharmacology & Therapeutics investigates mucosal healing with methotrexate vs azathioprine and infliximab in Crohn’s disease.
Mucosal healing has become a new therapeutic goal in Crohn’s disease and can be achieved with aza
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors